Join Us in Washington, DC for Rare Disease Week!
One-Day Narcolepsy Seminar in St. Petersburg, Florida
Year in Review
Axsome Therapeutics Announces AXS-12 Achieves Primary Endpoint in CONCERT Phase 2 Trial in Narcolepsy
Support Us on #GivingTuesday
Avadel Pharmaceuticals Achieves Enrollment Target in REST-ON Phase 3 Pivotal Trial of FT218
